Internal Medicine, Endocrinology, Diabetes, & Metabolism · Dearborn, MI
NPI
1912942582
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5250 Auto Club Dr, Ste 200
Dearborn, MI, 48126
Phone (313) 914-5591
Groups this clinician bills Medicare through
Medicare paid, 2024
$311K
18,401 services
Medicare patients, 2024
642
Average age 68
Drug cost, 2024
$7.1M
15,866 prescriptions
Company payments, 2025
$10K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Opada Alzohaili was code J1071 (injection, testosterone cypionate, 1 mg), 11,852 times for 18 patients. In total Opada Alzohaili billed 18,401 services in 43 codes, and Medicare paid $311K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 11,852 | 18 | $0.02 | $245 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,444 | 229 | $46.37 | $67K |
| 99214 Office E&M - Established | Office | 1,099 | 506 | $97.80 | $107K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 893 | 189 | $36.57 | $33K |
| 99457 E&M - Miscellaneous | Office | 642 | 168 | $37.81 | $24K |
| 82947 Clinical Chemistry | Office | 513 | 260 | $3.75 | $1,926 |
| 99454 E&M - Miscellaneous | Office | 481 | 135 | $35.99 | $17K |
| 95251 Test - Miscellaneous | Office | 245 | 134 | $26.78 | $6,561 |
| 96372 Injection Administration | Office | 200 | 81 | $11.19 | $2,237 |
| 99453 E&M - Miscellaneous | Office | 149 | 142 | $15.19 | $2,264 |
| 83036 Blood Count | Office | 141 | 116 | $9.13 | $1,287 |
| 76536 Ultrasound - Nonspecific | Office | 134 | 131 | $83.18 | $11K |
| 95250 Test - Miscellaneous | Office | 76 | 69 | $111.30 | $8,459 |
| 99442 Telephone Services | Office | 65 | 43 | $65.47 | $4,256 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 62 | 38 | $1.01 | $62.64 |
By year: 2022 $257K for 18,929 services; 2023 $296K for 13,356 services; 2024 $311K for 18,401 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 513 | 260 | $3.75 | $1,926 |
| 83036 Blood Count | 141 | 116 | $9.13 | $1,287 |
Medicare prescription drug claims, 2024
In 2024, the drug Opada Alzohaili prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 1,446 prescriptions and refills. In total Opada Alzohaili wrote 15,866 Medicare prescriptions that cost $7.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 1,446 | 1,932 | 297 | $1.1M |
| Levothyroxine Sodium Generic | 1,406 | 2,415 | 322 | $15K |
| Metformin Hcl Generic | 1,085 | 1,743 | 257 | $5,370 |
| Ozempic Semaglutide | 1,041 | 1,268 | 190 | $1.2M |
| Glimepiride Generic | 739 | 1,140 | 169 | $5,574 |
| Farxiga Dapagliflozin Propanediol | 631 | 809 | 118 | $447K |
| Trulicity Dulaglutide | 544 | 664 | 113 | $625K |
| Atorvastatin Calcium Generic | 481 | 773 | 141 | $3,053 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 388 | 733 | 123 | $44K |
| Januvia Sitagliptin Phosphate | 371 | 484 | 82 | $259K |
| Genotropin Somatropin | 362 | 371 | 45 | $720K |
| Mounjaro Tirzepatide | 301 | 352 | 67 | $360K |
| Rosuvastatin Calcium Generic | 283 | 374 | 63 | $1,747 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 248 | 435 | 94 | $18K |
| Testosterone Cypionate Generic | 244 | 298 | 58 | $6,134 |
Brand drugs: 8,207 claims; generic drugs: 5,978 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Opada Alzohaili $10K ($10K in general payments such as food, travel and fees) from 16 companies. The largest payer was Pfizer Inc. with $3,600.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.